Company Filing History:
Years Active: 2001
Title: Per Arvid Emil Carlsson: Innovator in Neurological and Psychiatric Treatments.
Introduction
Per Arvid Emil Carlsson is a notable inventor based in Goteborg, Sweden. He has made significant contributions to the field of neurological and psychiatric disorders through his innovative research. His work focuses on the modulation of monoaminergic neurotransmitter receptors, which are crucial for brain signaling.
Latest Patent Applications
Carlsson's latest patent application is titled "PHENYLPIPERIDINE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS." This application relates to the novel use of both enantiomers of the phenylpiperidine derivative OSU6162, specifically (−) and (+)-OSU6162, as partial agonists on 5-hydroxytryptamine (5-HT) receptors. The compounds may be utilized for the treatment and/or prevention of diseases that require modulation of these neurotransmitter receptors. This innovative approach aims to stabilize both dopaminergic and serotonergic brain signaling.
Conclusion
Per Arvid Emil Carlsson's work represents a significant advancement in the treatment of neurological and psychiatric disorders. His research on phenylpiperidine compounds showcases the potential for innovative therapies in this critical area of health.